MedPath

Subthalamic Nucleus, Akinesia and Parkinson's Disease

Not Applicable
Recruiting
Conditions
Parkinson's Disease
Interventions
Procedure: Bilateral subthalamic stimulation
Registration Number
NCT01682668
Lead Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Brief Summary

This program aims to understand the role of the subthalamic nucleus in the control of the movement in healthy humans and patients with Parkinson's disease, how the STN dysfunction contributes to akinesia and how the STN stimulation improves motor signs in PD patients .

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
180
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Frequency of subthalamic stimulationBilateral subthalamic stimulationComparison between healthy controls and PD patients (non-operable patients or who will be operated or already operated)
Primary Outcome Measures
NameTimeMethod
Firing rate of the subthalamic neuronsDuring surgery for bilateral STN stimulation

Changes in the neuronal activity of the STN before, during and after the execution of an arm movement

Secondary Outcome Measures
NameTimeMethod
Evoked related potentials of the STN3-5 days after surgery for bilateral STN stimulation

Local-field potentials recordings with DBS electrodes when performing the execution of an arm movement or gait initiation

Biomechanical parameters of gait initiation6 months

Gait initiation parameters by using a forceplate and EMG recordings

Trial Locations

Locations (2)

CIC-GHPS

🇫🇷

Paris, France

Groupe Hospitalier Pitie-Salpêtrière

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath